factors | n |
|---|
gender
| 61 m : 10 f |
age
| 59 (38–85) |
diagnosis
| |
oropharynx
| 32 |
oral cavity
| 22 |
hypopharynx
| 7 |
sinus
| 3 |
larynx
| 6 |
unknown, N+
| 1 |
T stages
| |
Tx | 1 |
T1 | 18 |
T2 | 21 |
T3 | 6 |
T4 | 12 |
recurrence * | 13 |
N stages
| |
N0 | 15 |
N1 | 4 |
N2a-b | 43 |
N2c | 6 |
N3 | 3 |
concomitant CT **
| 59 (83%) |
median/mean FU
| 17.6/19 months |
- Patient and tumor characteristics in 71 patients treated with postoperative SIB-IMRT
- *: recurrence following surgery alone (none of all patients underwent previous irradiation; all recurred lesions have been re-operated prior to postoperative IMRT)
- **: Cisplatinum based chemotherapy (in additional two patients with contraindications for cisplatinum, cetuximab has been given in combination with IMRT)
